| Degarelix (firmagon) for prostate cancer. [Journal Article, Review]
Med Lett Drugs Ther 2009 Oct 19; 51(1323):82-3.
Full Citation | Publisher Full Text | Find Related Articles | | Pitts WR
Key targets of hormone treatment of prostate cancer. Part I: the androgen receptor and steroidogenic pathways. [Journal Article]
BJU Int 2009 Nov; 104(9):1304.
Full Citation | Publisher Full Text | | Kramer KM, Perry AN, Golbin D, et al.
Sex steroids are necessary in the second postnatal week for the expression of male alloparental behavior in prairie voles (Microtus ochragaster). [Journal Article]
Behav Neurosci 2009 Oct; 123(5):958-63.
Abstract | Full Citation | | Chen Y, Clegg NJ, Scher HI
Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.]
Lancet Oncol 2009 Oct; 10(10):981-91.
Abstract | Full Citation | Find Related Articles | | Johnke RM, Edwards JM, Evans MJ, et al.
Circulating cytokine levels in prostate cancer patients undergoing radiation therapy: influence of neoadjuvant total androgen suppression. [Journal Article]
In Vivo 2009 Sep-Oct; 23(5):827-33.
Abstract | Full Citation | Find Related Articles | | Richaud P, Hennequin C
[In Process Citation] [English Abstract, Journal Article]
Cancer Radiother 2009 May.:1-7.
Abstract | Full Citation | | Badiozamani KR
Duration of androgen suppression in prostate cancer. [Comment, Letter]
N Engl J Med 2009 Sep 17; 361(12):1212; author reply 1212-3.
Full Citation | Find Related Articles | | Rosser CJ
Editorial comment. [Comment, Editorial]
J Urol 2009 Nov; 182(5):2272; discussion 2273.
Full Citation | Publisher Full Text | Find Related Articles | | Sharma P, Wisniewski A, Braga-Basaria M, et al.
Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. [Journal Article]
J Urol 2009 Nov; 182(5):2265-72.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bhoopalam N, Campbell SC, Moritz T, et al.
Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy. [Journal Article, Research Support, Non-U.S. Gov't]
J Urol 2009 Nov; 182(5):2257-64.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
